Market Tracker

12/02 1:00pm ET

Mesoblast Ltd (NASDAQ:MESO)

4.72
Delayed Data
As of 12:34pm ET
 +0.20 / +4.42%
Today’s Change
3.50
Today|||52-Week Range
10.89
-25.79%
Year-to-Date
No recent news for Mesoblast Ltd.

Today’s Trading

Previous close4.52
Today’s open4.63
Day’s range4.63 - 4.77
Volume2,628
Average volume (3 months)18,342
Market cap$341.9M
Dividend yield--
Data as of 12:34pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)+96.32%
Earnings growth (this year)-791.23%
Earnings growth (next 5 years)-0.34%
Revenue growth (last year)+143.13%
P/E ratio--
Price/Sales6.89
Price/Book0.65

Competitors

 Today’s
change
Today’s
% change
IVCInvacare Corp+0.20+1.76%
CFMSConforMIS Inc+0.02+0.23%
RTIXRTI Surgical Inc+0.08+2.59%
SIENSientra Inc+0.02+0.24%
Data as of 1:00pm ET, 12/02/2016

Financials

Next reporting dateFebruary 27, 2017
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$41.5M
Annual profit (last year)-$4.1M
Net profit margin-9.95%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, MD &
Executive Director
Silviu Itescu
Chief Financial Officer
Paul Hodgkinson
Corporate headquarters
Melbourne, Victoria (vic)

Forecasts